Amanote Research
Register
Sign In
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA - Journal of the American Medical Association
- United States
doi 10.1001/jama.284.15.1931
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
October 18, 2000
Authors
Unknown
Publisher
American Medical Association (AMA)
Related search
Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Archives of Neurology
Late Onset Levodopa Responsive Huntington's Disease With Minimal Chorea Masquerading as Parkinson Plus Syndrome
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Levodopa as Treatment for Adults With Amblyopia
Revista de Chimie
Surfaces
Materials Science
Engineering
Materials Chemistry
Films
Coatings
Chemistry
Surgical Treatment of Parkinson Disease
Neurologic Clinics
Neurology
Gene Therapy for Parkinson Disease(Parkinson Disease)
Japanese Journal of Neurosurgery
Surgery
Neurology
Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
Frontiers in Neurology
Neurology
Clozapine for the Treatment of Levodopa and Dyskinesia in Parkinson's Disease
Irish Journal of Psychological Medicine
Psychiatry
Mental Health
Philosophy of Science
Applied Psychology
History
Long-Term Retention Rate of Pramipexole in the Treatment of Parkinson’s Disease
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management
